Examining Oncolytic Poliovirus Bioactivity in Tumor Tissue After Intratumoral Administration of PVSRIPO in Women With Invasive Breast Cancer
Phase of Trial: Phase 0
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Recombinant polio virus vaccine Istari Oncology (Primary)
- Indications Advanced breast cancer; Early breast cancer
- Focus Pharmacodynamics
- Sponsors Istari Oncology
- 15 Mar 2019 Planned initiation date changed from (estimated date for recruitment of the first subject) 24 Sep 2018 to 15 Apr 2019.
- 21 Sep 2018 Planned initiation date changed from 1 Sep 2018 to 24 Sep 2018.
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.